These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

125 related articles for article (PubMed ID: 37477212)

  • 1. Clinical profile and outcome of children with anaplastic large cell lymphoma treated with short-course chemotherapy - ten years experience from a tertiary care center in a LMIC.
    Trivedi M; Thankamony P; Nair M; Rajeswari B; Guruprasad CS; Prasanth VR; Nair RA; Jagathnath Krishna KM
    Pediatr Hematol Oncol; 2023; 40(5):485-496. PubMed ID: 37477212
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Diagnosis and treatment of anaplastic large-cell lymphoma in children and adolescents: a retrospective multicenter survey study].
    ;
    Zhonghua Er Ke Za Zhi; 2017 Mar; 55(3):194-199. PubMed ID: 28273702
    [No Abstract]   [Full Text] [Related]  

  • 3. [Clinical analysis of 60 children with anaplastic large cell lymphoma in a single center].
    Wang M; Mi Q; Yuan Q; Han YL; Wang JM; Luo CY; Pan C; Tang JY; Gao YJ
    Zhonghua Er Ke Za Zhi; 2021 Oct; 59(10):824-829. PubMed ID: 34587677
    [No Abstract]   [Full Text] [Related]  

  • 4. Anaplastic large cell lymphoma: a single institution experience from India.
    Lakshmaiah KC; Guruprasad B; Shah A; Kavitha S; Abraham LJ; Govindbabu K; Aruna Kumari BS; Appaji L
    J Cancer Res Ther; 2013; 9(4):649-52. PubMed ID: 24518711
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Short-pulse B-non-Hodgkin lymphoma-type chemotherapy is efficacious treatment for pediatric anaplastic large cell lymphoma: a report of the Berlin-Frankfurt-Münster Group Trial NHL-BFM 90.
    Seidemann K; Tiemann M; Schrappe M; Yakisan E; Simonitsch I; Janka-Schaub G; Dörffel W; Zimmermann M; Mann G; Gadner H; Parwaresch R; Riehm H; Reiter A
    Blood; 2001 Jun; 97(12):3699-706. PubMed ID: 11389005
    [TBL] [Abstract][Full Text] [Related]  

  • 6. ALK expression plays different roles in anaplastic large-cell lymphomas and outcome of crizotinib use in relapsed/refractory ALK+ patients in a Chinese population.
    Huang L; Zhang F; Zeng J; Guo H; Liu S; Wei X; Chen F; Jiang X; Liang Z; Liu Y; Li W
    Ann Hematol; 2018 Jan; 97(1):149-159. PubMed ID: 29150811
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Efficacy of peripheral blood stem cell transplantation versus conventional chemotherapy on anaplastic large-cell lymphoma:a retrospective study of 64 patients from a single center.
    He XH; Li B; Zou SM; Dong M; Zhou SY; Yang JL; Xue LY; Yang S; Liu P; Qin Y; Zhang CG; Han XH; Shi YK
    Chin J Cancer; 2012 Nov; 31(11):532-40. PubMed ID: 22854061
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Predictors of Outcome in Pediatric Anaplastic Large Cell Lymphoma.
    Patel A; Pushpam D; Sharma MC; Thulkar S; Bakhshi S
    Indian Pediatr; 2020 Jun; 57(6):523-526. PubMed ID: 32562396
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Clinical Features and Treatment Outcomes of Children with Anaplastic Large Cell Lymphoma.
    Mehreen A; Wali R; Riaz S
    J Coll Physicians Surg Pak; 2020 Jul; 30(7):749-753. PubMed ID: 32811608
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Clinical features and treatment results in children with anaplastic large cell lymphoma.
    Ataş E; Kutluk MT; Akyüz C; Kale G; Varan A; Yalçın B; Aydın B; Büyükpamukçu M
    Turk J Pediatr; 2015; 57(5):458-66. PubMed ID: 27411412
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Intensive chemotherapy without radiotherapy gives more than 85% event-free survival for non-Hodgkin lymphoma without central nervous involvement: a 6-year population-based study from the nordic society of pediatric hematology and oncology.
    Márky I; Björk O; Forestier E; Jónsson OG; Perkkiö M; Schmiegelow K; Storm-Mathiesen I; Gustafsson G;
    J Pediatr Hematol Oncol; 2004 Sep; 26(9):555-60. PubMed ID: 15342981
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Treatment outcome of Chinese children with anaplastic large cell lymphoma by using a modified B-NHL-BFM-90 protocol.
    Sun X; Zhen Z; Lin S; Zhu J; Wang J; Lu S; Chen Y; Zhang F; Sun F; Li P
    Pediatr Hematol Oncol; 2014 Sep; 31(6):518-27. PubMed ID: 25116372
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Results of AIEOP LNH-97 protocol for the treatment of anaplastic large cell lymphoma of childhood.
    Pillon M; Gregucci F; Lombardi A; Santoro N; Piglione M; Sala A; D'Amore ES; De Santis R; Casale F; Zecca M; Mussolin L; Rosolen A;
    Pediatr Blood Cancer; 2012 Nov; 59(5):828-33. PubMed ID: 22389307
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Clinicopathological features and prognostic significance of programmed death ligand 1 in pediatric ALK-positive anaplastic large cell lymphoma: results of the ALCL99 treatment in Japan.
    Iwafuchi H; Nakazawa A; Sekimizu M; Mori T; Osumi T; Iijima-Yamashita Y; Ohki K; Kiyokawa N; Fukano R; Saito AM; Horibe K; Kobayashi R;
    Hum Pathol; 2021 Oct; 116():112-121. PubMed ID: 34363798
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Favorable outcomes and reduced toxicity with a novel vinblastine-based non-high dose methotrexate (HDMTX) regimen (modified MCP-842) in pediatric anaplastic large cell lymphoma (ALCL): experience from India.
    Vijayasekharan K; Prasad M; Pradhan ND; Phillip D; Gujral S; Shet T; Sridhar E; Kembhavi S; Shah S; Banavali SD; Narula G
    Leuk Lymphoma; 2020 Apr; 61(4):912-918. PubMed ID: 31774004
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Prognostic Factors and Treatment Outcome of Pediatric Anaplastic Large Cell Lymphoma Treated at the Children Cancer Hospital Egypt.
    Abdel Rahman H; El Semary S; Sedky M; Atteya I; El Kinaaie N; El Wakeel M; Hassanein O; Mohy R
    J Pediatr Hematol Oncol; 2019 Oct; 41(7):e427-e431. PubMed ID: 31343479
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Successful treatment strategy for Ki-1 anaplastic large-cell lymphoma of childhood: a prospective analysis of 62 patients enrolled in three consecutive Berlin-Frankfurt-Munster group studies.
    Reiter A; Schrappe M; Tiemann M; Parwaresch R; Zimmermann M; Yakisan E; Dopfer R; Bucsky P; Mann G; Gadner H
    J Clin Oncol; 1994 May; 12(5):899-908. PubMed ID: 8164040
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Anaplastic large cell lymphoma, ALK-negative.
    Ferreri AJ; Govi S; Pileri SA; Savage KJ
    Crit Rev Oncol Hematol; 2013 Feb; 85(2):206-15. PubMed ID: 22789917
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Clinical Features and Treatment Outcomes of Children With Anaplastic Large Cell Lymphoma in Pakistan: A Multicenter Study.
    Resham S; Khan R; Ashraf S; Rizvi A; Altaf S
    J Pediatr Hematol Oncol; 2019 May; 41(4):298-302. PubMed ID: 30855316
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Results of treatment of lymphoblastic lymphoma at the children cancer hospital Egypt - A single center experience.
    Rahman Sayed HA; Sedky M; Hamoda A; Kinaaie NE; Wakeel ME; Hesham D
    J Egypt Natl Canc Inst; 2016 Sep; 28(3):175-81. PubMed ID: 27339800
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.